Searchable abstracts of presentations at key conferences in endocrinology

ea0011p721 | Reproduction | ECE2006

Serum Anti-Mullerian hormone (AMH) concentrations in infants and children

Wilson G , Fleming R , Galloway P , Wallace AM , Ahmed SF

Introduction: AMH is produced by the sertoli cells in the testes and is responsible for the regression of the Mullerian structures in the male fetus. It is also produced by the granulosa cells of the ovaries in females to a lesser degree. Serum AMH measurements may be important for detecting testicular tissue and monitoring ovarian activity. The objective of this study was to establish a cross-sectional reference range for AMH in UK children.Method: Seru...

ea0009p83 | Growth and development | BES2005

Differential effects of pregnancy on different high molecular mass forms of serum prolactin

Ahlquist J , Dearman G , Fahie-Wilson M , Everitt A

Macroprolactin is a high molecular mass prolactin isoform found in some normal individuals. The most common form of macroprolactin arises from binding of prolactin to IgG ('big-big' prolactin), with a molecular mass 150-170 kD. A further prolactin isoform of intermediate size ('big' prolactin, 50-60 kD), has also been described but the nature and significance of this form is less clearly understood.We have previously described the effects of pregnancy in...

ea0008s4 | Basic Science Review Lecture | SFE2004

Understanding endocrine development of the human beta cell: guiding stem cell therapy for Type 1 Diabetes

Piper K , Dunleavey L , Cameron I , Wilson D , Hanley N

Stem cell therapy offers a far-sighted opportunity to cure Type 1 diabetes. To achieve this ambitious goal, an in depth understanding of how human beta cells normally develop is critical, as it provides the perfect model for the differentiation of stem cells down normal safe developmental pathways. Our data provide a framework of human pancreas development and islet formation, highlighting subtle differences from the parallel process in mouse. Key genes have been identified th...

ea0005p218 | Steroids | BES2003

Studies on functional activity of human ERbeta wild type and variant isoforms

Sierens J , Scobie G , Wilson J , Saunders P

Oestrogens act via oestrogen receptors (ER) that are expressed in a wide range of tissues including the vasculature, bone and gonads. Two ER genes known as ERalpha and ERbeta have been identified. In the human splice variants of ERbeta have been identified. ERs form both homodimers and heterodimers upon ligand binding. The aim of the present experiments was to study the functional activity of ERbeta1 (wild type) and ERbeta variant (ERbeta2) in single and double transfection as...

ea0003p213 | Reproduction | BES2002

Detection of bio-inactive prolactin (macroprolactin) is analyser dependant

Smith T , Suliman A , Fahie-Wilson M , McKenna T

Macroprolactin, a high molecular mass complex of prolactin and an IgG antibody is confined to the vasculature and exhibits limited bioactivity in vivo. Using a panel of sera obtained from 10 subjects whose hyperprolactinaemia was due entirely to macroprolactin this study aims to compare the level of detection of macroprolactin by 9 of the most commonly used prolactin immunoassays.The study involved 24 clinical laboratories employing the following 9 anal...

ea0077oc3.4 | Metabolism, Obesity and Diabetes | SFEBES2021

Hepatic choline deficiency underpins amelioration of visceral obesity and diabetes in ectonucleotide pyrophosphatase (Enpp)-6–/– mice

Wang Rongling , Schraut Katharina , Carter Roderick , Kentistou Katherine , Wilson James , Michailidou Zoi , Webster Scott , Morton Nicholas

The global prevalence of obesity continues to rise, creating a growing need for new effective medicines. Selective targeting of visceral obesity (fat around the internal organs) would be particularly advantageous because it carries a greater risk for cardiometabolic diseases. The ectonucleotide pyrophosphatase (ENPP) enzyme family participates in several pathological conditions including diabetes (ENPP1, and ENPP2, also known as autotaxin) and vascular dysfunction (ENPP3-4). O...

ea0051oc3.2 | Oral Communications 3 | BSPED2017

A novel syndrome of nephrogenic syndrome of inappropriate antidiuresis, precocious puberty, parathyroid insensitivity associated with a novel GNAS mutation, p.F376V

Tully Ian , Kiff Sarah , Bockenhauer Detlef , Wilson Louise , Allgrove Jeremy , Gregory John , Dattani Mehul

Introduction: Mutations in GNAS, affecting the alpha subunit of heterotrimeric G proteins, are implicated in several endocrinopathies. We report a patient with features of both receptor activation and inactivation in association with a novel de novo heterozygous somatic mutation.Case report: Asymptomatic hyponatraemia (Na 117-123) was identified in a male neonate, and treated with sodium supplementation and fludrocortisone. Biochemical data were...

ea0069p61 | Poster Presentations | SFENCC2020

A case of pulmonary neuroendocrine tumours secreting ACTH and GHRH

Lee Yun-Ni , Jiwan Riyah , Sahdev Anju , Berney Daniel , Wilson Henrietta , Akker Scott , Davies Zoe

Section 1: Case history: A sixty-three-year-old Caucasian male presented with a six-week history of lethargy, emotional lability, polydipsia, polyuria, increased appetite and weight gain. He also reported changes in his facial features and widening of the gaps between his teeth. He has a background of hypertension, obstructive sleep apnoea and benign prostatic hyperplasia. On examination, the patient appeared plethoric, had coarsened facial features, mild prognathism and evide...

ea0065p210 | Metabolism and Obesity | SFEBES2019

All cause and cardiovascular mortality in adults with schizophrenia and diabetes – a retrospective matched study

Morrison Deborah , Frize Ryan , Sainsbury Christopher A , Wilson Ruairi , Jones Gregory C

Introduction: Increased prevalence of diabetes is found in major psychosis, and poorer outcomes occur when both diagnoses co-exist. The aim of this study was to describe the association between total and cardiovascular mortality in people with both schizophrenia and diabetes, compared to diabetes alone.Materials and methods: Data was linked from the Glasgow Psychosis Clinical Information System (PsyCIS), the Scottish national diabetes database (SCI-Diabe...

ea0063p48 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Pharmacokinetic Interaction Study of the Effects of Multiple-dose Gastric Acid Reducers Omeprazole (OMP) and Famotidine (FAM on the Pharmacokinetics (PK) of Single-dose Telotristat Etiprate (TE) in Healthy Subjects

Wilson Alan , Qubeck Christine , Warner Chris , Tesfaye Eshetu , Nguyen Quyen , Wason Suman

Background: TE is indicated for the treatment of carcinoid syndrome diarrhea in patients with metastatic neuroendocrine tumors.Objective: To evaluate the effects of a proton pump inhibitor (OMP) and H2 antagonist (FAM) on the PK of TE and its active metabolite LP-778902 via an open-label study of OMP (40 mg orally QD × 4 days) or FAM (40 mg orally BID × 4 days) with a single 250 mg oral dose of TE. Eligible subjects: healthy, nonsmoking, aged &...